Once-weekly oral islatravir plus lenacapavir: clinical considerations for individualized use. Fusco P, Russo A. J Acquir Immune Defic Syndr 2026 Aug 24. doi: 10.1097/QAI.0000000000003960.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fusco P, Russo A. Once-weekly oral islatravir plus lenacapavir: clinical considerations for individualized use. J Acquir Immune Defic Syndr 2026 Aug 24. doi: 10.1097/QAI.0000000000003960.
PMID: 42636794